- Report
- February 2024
- 85 Pages
North America
From €1481EUR$1,500USD£1,233GBP
- Report
- February 2024
- 97 Pages
Africa, Middle East
From €1481EUR$1,500USD£1,233GBP
- Report
- February 2024
- 96 Pages
Europe
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2024
- 100 Pages
Africa
From €1975EUR$2,000USD£1,643GBP
- Report
- May 2024
- 100 Pages
Africa
From €1975EUR$2,000USD£1,643GBP
- Report
- May 2024
- 80 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2024
- 80 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2024
- 80 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2024
- 80 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2024
- 80 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2024
- 100 Pages
Africa
From €1975EUR$2,000USD£1,643GBP
- Report
- April 2024
- 100 Pages
Africa
From €1975EUR$2,000USD£1,643GBP
- Report
- April 2024
- 100 Pages
Africa
From €1975EUR$2,000USD£1,643GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €938EUR$950USD£781GBP
- Report
- October 2024
- 70 Pages
Latin America
From €938EUR$950USD£781GBP
- Report
- October 2024
- 70 Pages
Europe
From €938EUR$950USD£781GBP
- Report
- October 2024
- 70 Pages
Latin America
From €938EUR$950USD£781GBP
- Report
- July 2024
- 134 Pages
Africa
From €4504EUR$4,560USD£3,747GBP
- Report
- May 2024
- 51 Pages
United States
From €1081EUR$1,095USD£900GBP
- Report
- November 2023
- 92 Pages
Asia Pacific
From €3407EUR$3,450USD£2,835GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more